Skip to content

Search

Showing results for "1"

Variation in nutrition education practices in SWEET pediatric diabetes centers-an international comparison

Nutrition education is central to pediatric type 1 diabetes management. Dietary management guidelines for type 1 diabetes are evidence based, but implementation may be challenging and inconsistent. We describe variation in the practice of nutrition education across pediatric diabetes centers globally and explore associations with A1c and BMI.

New clinics for younger children

In order to meet the rising needs of all children with type 1 diabetes and their families in WA, PCH's Diabetes Service will offer additional clinics in 2021.

Major focus for children's diabetes research in WA

Research into childhood diabetes in Perth has been given a major boost with the launch of the WA Children's Diabetes Research and Education Centre for Research Excellence (CRE) on the eve of World Diabetes Day.

Publications

Browse the published work of the Centre's researchers

The Cashew Study

Does eating cashew nut spreads in the first year of life reduce the chances a baby will develop a cashew nut food allergy?

Mentor project gets the thumbs up

Young adult and parent peer mentors can be role models who not only normalise experiences of living with type 1 diabetes but can act as symbols of hope, new Children’s Diabetes Centre research has found.

Sprint study

Join us in Western Australia's first home-based study looking at the effect of sprinting during exercise in Type 1 Diabetes.

Ten Day Continuous Glucose Monitoring study – now recruiting

The Children’s Diabetes Centre is now recruiting for a new continuous glucose monitoring study.

Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD

Mitophagy preserves overall mitochondrial fitness by selectively targeting damaged mitochondria for degradation. The regulatory mechanisms that prevent PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin (PINK1/Parkin)-dependent mitophagy and other selective autophagy pathways from overreacting while ensuring swift progression once initiated are largely elusive. 

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV

To evaluate the safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F, 22F, 23F, 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in children with HIV.